Literature DB >> 30190802

Advances in molecular profiling of malignant melanoma: ready for clinical practice?

Göran Jönsson.   

Abstract

Entities:  

Keywords:  BRAF; gene expression; melanoma; mutation

Year:  2014        PMID: 30190802      PMCID: PMC6096433          DOI: 10.2217/mmt.14.5

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


× No keyword cloud information.
  24 in total

1.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

2.  Inhibition of mutated, activated BRAF in metastatic melanoma.

Authors:  Keith T Flaherty; Igor Puzanov; Kevin B Kim; Antoni Ribas; Grant A McArthur; Jeffrey A Sosman; Peter J O'Dwyer; Richard J Lee; Joseph F Grippo; Keith Nolop; Paul B Chapman
Journal:  N Engl J Med       Date:  2010-08-26       Impact factor: 91.245

3.  BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

Authors:  Graham J Mann; Gulietta M Pupo; Anna E Campain; Candace D Carter; Sarah-Jane Schramm; Svetlana Pianova; Sebastien K Gerega; Chitra De Silva; Kenneth Lai; James S Wilmott; Maria Synnott; Peter Hersey; Richard F Kefford; John F Thompson; Yee Hwa Yang; Richard A Scolyer
Journal:  J Invest Dermatol       Date:  2012-08-30       Impact factor: 8.551

4.  Patterns of expression of DNA repair genes and relapse from melanoma.

Authors:  Rosalyn Jewell; Caroline Conway; Angana Mitra; Juliette Randerson-Moor; Samira Lobo; Jérémie Nsengimana; Mark Harland; Maria Marples; Sara Edward; Martin Cook; Barry Powell; Andy Boon; Floor de Kort; Katharine A Parker; Ian A Cree; Jennifer H Barrett; Margaret A Knowles; D Timothy Bishop; Julia Newton-Bishop
Journal:  Clin Cancer Res       Date:  2010-08-12       Impact factor: 12.531

5.  Molecular profiling reveals low- and high-grade forms of primary melanoma.

Authors:  Katja Harbst; Johan Staaf; Martin Lauss; Anna Karlsson; Anna Måsbäck; Iva Johansson; Pär-Ola Bendahl; Johan Vallon-Christersson; Therese Törngren; Henrik Ekedahl; Jürgen Geisler; Mattias Höglund; Markus Höglund; Markus Ringnér; Mattias Ringnér; Lotta Lundgren; Karin Jirström; Håkan Olsson; Christian Ingvar; Åke Borg; Hensin Tsao; Göran Jönsson
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

6.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Authors:  Jeffrey A Sosman; Kevin B Kim; Lynn Schuchter; Rene Gonzalez; Anna C Pavlick; Jeffrey S Weber; Grant A McArthur; Thomas E Hutson; Stergios J Moschos; Keith T Flaherty; Peter Hersey; Richard Kefford; Donald Lawrence; Igor Puzanov; Karl D Lewis; Ravi K Amaravadi; Bartosz Chmielowski; H Jeffrey Lawrence; Yu Shyr; Fei Ye; Jiang Li; Keith B Nolop; Richard J Lee; Andrew K Joe; Antoni Ribas
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

7.  Predicting clinical outcome through molecular profiling in stage III melanoma.

Authors:  Thomas John; Michael A Black; Tumi T Toro; Debbie Leader; Craig A Gedye; Ian D Davis; Parry J Guilford; Jonathan S Cebon
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

8.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Authors:  Michael Krauthammer; Yong Kong; Byung Hak Ha; Perry Evans; Antonella Bacchiocchi; James P McCusker; Elaine Cheng; Matthew J Davis; Gerald Goh; Murim Choi; Stephan Ariyan; Deepak Narayan; Ken Dutton-Regester; Ana Capatana; Edna C Holman; Marcus Bosenberg; Mario Sznol; Harriet M Kluger; Douglas E Brash; David F Stern; Miguel A Materin; Roger S Lo; Shrikant Mane; Shuangge Ma; Kenneth K Kidd; Nicholas K Hayward; Richard P Lifton; Joseph Schlessinger; Titus J Boggon; Ruth Halaban
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.